UCB (BE.UCB) - 122.75 EUR (%)

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 122.7000 EUR
Ask 122.8000 EUR
Minim 118.7000 EUR
Maxim 121.1000 EUR
Pret referinta 121.2000
Volum -
Volum ultima zi 1
Max 52 sapt 122.6000 EUR
Min 52 sapt 65.5800 EUR

Descriere companie

Ucb SA (https://www.ucb.com/) is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Informatii companie

Nume

UCB

Buna ziua, sunt TreVi. Spuneti-mi, va rog, cu ce informatii va pot fi de folos.